BioXcel Therapeutics
BTAI
NZ$2.67
Share price
-6.47%
Change (1 day)
-91.59%
Change (1 year)
Categories
BioXcel Therapeutics (BTAI) - Cash on Hand
Cash on Hand as of March 2025 : NZ$52.03 Million
According to BioXcel Therapeutics's latest financial reports the company has NZ$52.03 Million in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
BioXcel Therapeutics - Cash on Hand chart (from 2017 to 2025)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | NZ$0.10 B | -66.2% |
| 2022-12-31 | NZ$0.30 B | -10.54% |
| 2021-12-31 | NZ$0.34 B | 15.47% |
| 2020-12-31 | NZ$0.29 B | 513.47% |
| 2019-12-31 | NZ$48.14 M | -24.13% |
| 2018-12-31 | NZ$63.45 M | 4980.85% |
| 2017-12-31 | NZ$1.24 M | |
| 2016-12-31 | N/A |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | NZ$0.34 B | 556.90% | 🇺🇸 USA |